April 3, 2017
Alcon Pharma President David Rylett Alcon Pharma, a new company created through the integration of Novartis Pharma’s ophthalmology division and Alcon Japan’s pharma unit, started operations on April 1. The launch of the company comes as part of Novartis AG’s...read more